BioTuesdays

Tag - FSTX

F-star Therapeutics logo

SVB Leerink starts F-Star Therapeutics at OP; PT $39

SVB Leerink launched coverage of F-Star Therapeutics (NASDAQ:FSTX) with an “outperform” rating and $39 price target. The stock closed at $7.34 on July 7. F-star’s pipeline generates drug candidates that work with...